Lv3
230 积分 2025-07-02 加入
Abstract 6409: AI-accelerated discovery of B7-H3 and DLL3-targeted cyclic peptide radioligands: From library design to preclinical validation
11天前
已关闭
An Overview of Radiolabeled RGD Peptides for Theranostic Applications
19天前
已完结
An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases
19天前
已完结
Molecular craftsmanship: reforging peptide backbones for enhanced drug design
19天前
已完结
Development of a 177Lu-labeled radiopeptide for targeted CXCR4 positive tumor therapy
20天前
已完结
Preclinical pharmacokinetics, biodistribution, excretion, and plasma protein binding study of 58Fe-labeled hemin by ICP-MS
26天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
1个月前
已完结
The Influence of Disulfide, Thioacetal and Lanthionine‐Bridges on the Conformation of a Macrocyclic Peptide
1个月前
已关闭
LUNA18, a macrocyclic orally bioavailable peptide pan-RAS inhibitor, discovered from a beyond rule of 5 drug discovery platform
1个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
3个月前
已完结
皖公网安备34019202002308
